Glutathione S-transferases: an overview in cancer research

Bibliography

• Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000;112-113:357-363
   PubMed Web of Science ®Google Scholar
• Coleman JOD, Blake-Kalff MMA, Davies TGE. Detoxification of xenobiotics by plants: chemical modification and vacuolar compartmentation. Trends Plant Sci 1997;2:144-151
   Web of Science ®Google Scholar
• Board PG, Coggan M, Chelvanayagam G, Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 2000;275:24798-806
   PubMed Web of Science ®Google Scholar
• Axarli IA, Ridgen DJ, Labrou NE. Characterization of the ligandin site of maize glutathione S-transferase I. Biochem J 2004;382:885-93
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88
   PubMed Web of Science ®Google Scholar
• Morel F, Rauch C, Petit E, Gene and protein characterization of the human glutathione S-Transferase kappa and evidence for a peroxisomal localization. J. Biol Chem 2004;279:16246-53
   Web of Science ®Google Scholar
• Frova C. Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 2006;23:149-69
   PubMedGoogle Scholar
• Ji XH, von Rosenvinge EC, Johnson WW, 3-Dimensional structure, catalytic properties, and evolution of a sigma-class glutathione transferase from squid, a progenitor of the lens S-crystallins of cephalopods. Biochemistry 1995;34:5317-28
   PubMed Web of Science ®Google Scholar
• Ryberg D, Skaug V, Hewer A, Genotypes of glutathione transferase M1 and P1 and their significance for lung adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9
   PubMed Web of Science ®Google Scholar
• Morel F, Rauch C, Coles B, The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 2002;12:277-86
   PubMedGoogle Scholar
• Coles BF, Morel F, Rauch C, Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001;11:663-9
   PubMedGoogle Scholar
• Ning B, Wang C, Morel F, Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics 2004;14:35-44
   PubMedGoogle Scholar
• Xu SJ, Wang, YP, Characterization of the human class mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem 1998;273:3517-27
   PubMed Web of Science ®Google Scholar
• Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43
   PubMed Web of Science ®Google Scholar
• Widersten M, Pearson WR, Engstrom A, Heterologous expression of the allelic variant μ-class glutathione transferases μ and θ. Biochem J 1991;276:519-24
   PubMed Web of Science ®Google Scholar
• Rocha JC, Cheng C, Liu W, Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005;105:4752-8
   PubMed Web of Science ®Google Scholar
• Inskip A, Elexperu-Camiruaga J, Buxton N, Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 1995;312:713-16
   PubMed Web of Science ®Google Scholar
• Hu X, O'Donnell R, Srivastava SK, Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7beta, 8alpha-dihydroxy- 9alpha,10alpha-oxy-7,8,9,10- tetrahydrobenzo(a)pyrene. Biochem Biophys Res Commun 1997;235:424-8
   PubMed Web of Science ®Google Scholar
• Ali-Osman F, Akande O, Antoun G, Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase pi gene variants. J Biol Chem 1997;272:10004-12
   PubMed Web of Science ®Google Scholar
• Watson MA, Stewart RK, Smith GB, Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-80
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Wolf CR. Disruption of the glutathione transferase pi class genes. Methods Enzymol 2005;401:116-35
   PubMed Web of Science ®Google Scholar
• Landi S. Mammalian class Theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83
   PubMed Web of Science ®Google Scholar
• Pemble SE, Taylor JB. An evolutionary perspective on glutathione transferases inferred from class-theta glutathione transferase cDNA sequences. Biochem J 1992;287:957-63
   PubMed Web of Science ®Google Scholar
• Meyer DJ, Coles B, Pemble SE, Theta, a new class of glutathione transferases purified from rat and man. Biochem J 1991;274:409-14
   PubMed Web of Science ®Google Scholar
• Sprenger R, Schlagenhaufer R, Kerb R, Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 2000;10:557-65
   PubMedGoogle Scholar
• Bruhn C, Brockmoller J, Kerb R, Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 1998;56:1189-93
   PubMed Web of Science ®Google Scholar
• Alexandrie AK, Rannug A, Juronen E, Detection and characterization of a novel functional polymorphism in the GSTT1 gene. Pharmacogenetics 2002;12:613-19
   PubMedGoogle Scholar
• Whitbread AK, Tetlow N, Eyre HJ, Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 2003;13:131-44
   PubMedGoogle Scholar
• Yim JJ, Yoo CG, Lee CT, Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung 2002;180:2:119-25
   PubMed Web of Science ®Google Scholar
• Tanaka-Kagawa T, Jinno H, Hasegawa T, Functional characterization of two variant human GSTO1-1s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 2003;301:516-20
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Salavaggione OE, Pelleymounter LL, Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 2006;34:1237-46
   PubMed Web of Science ®Google Scholar
• Bolt HM, Parra FC, Amado RC, Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006;7:613-28
   PubMed Web of Science ®Google Scholar
• Garte S, Gaspari L, Alexandrie AK, Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48
   PubMed Web of Science ®Google Scholar
• Fonte de Amorim L, Rossini A, Mendonca G, CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett 2002;181:179-86
   PubMed Web of Science ®Google Scholar
• Rossini A, Davy CM, Rapozo DCM, Frequencies of GSTM1, GSTT1, and GSTP1polymorphisms in a Brazilian population. Genet Mol Res 2002;1:233-40
   PubMedGoogle Scholar
• Gattás GJF, Kato M, Soares-Vieira JA, Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population GST polymorphism and ethnicity in Brazil. Braz J Med Biol Res 2004;37:451-8
   PubMed Web of Science ®Google Scholar
• Hatagima A, Marques CFS, Krieger H, Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms in a Brazilian mixed population. Hum Biol 2004;76:937-42
   PubMed Web of Science ®Google Scholar
• Suarez-Kurtz G, Vargens DD, Struchiner CJ, Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms. Pharmacogenet Genomics 2007;17:765-71
   PubMed Web of Science ®Google Scholar
• Magno LAV, Jhimmy Talbot J, Teddy Talbot T, Glutathione S-transferase variants in a Brazilian population. Pharmacology 2009;83:231-6
   PubMed Web of Science ®Google Scholar
• Hiragi CO, Oliveira SF, Hatagima A, Glutathione S-transferase M1 and T1 polymorphisms in Brazilian African descendants. Hum Biol 2007;79:131-40
   PubMed Web of Science ®Google Scholar
• Nelson SA, Wiencke JK, Christiani DC, Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995;16:243-5
   Google Scholar
• Abdel-Rahman SZ, El-Zein RA, Anwar WA, A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996;107:229-33
   PubMed Web of Science ®Google Scholar
• Buchard A, Sanchez JJ, Kim Dalhoff K, Multiplex PCR Detection of GSTM1, GSTT1, and GSTP1 Gene Variants: Simultaneously Detecting GSTM1 and GSTT1 Gene Copy Number and the Allelic Status of the GSTP1 Ile105Val Genetic Variant. J Mol Diagn 2007;9:612-17
   PubMed Web of Science ®Google Scholar
• Steinhoff C, Franke KH, Golka K, Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000;74:521-6
   PubMed Web of Science ®Google Scholar
• Schneider J, Bernges U, Philipp M, GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 2004;10:65-74
   Google Scholar
• Jee SH, Lee JE, Kim S. GSTP1 polymorphism, cigarette smoking and cervical cancer risk in Korean women. Yonsei Med J 2002;43:6:712-6
   PubMed Web of Science ®Google Scholar
• Cho HJ, Lee SY, Ki CS, GSTM1, GSTT1 and GSTP1 polymorphisms in the Korean population. J Korean Med Sci 2005;20:1089-92
   PubMed Web of Science ®Google Scholar
• Zhong S, Huang M, Yang X, Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 2006;62:457-72
   PubMed Web of Science ®Google Scholar
• Wang J, Deng Y, Cheng J, GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93
   PubMed Web of Science ®Google Scholar
• Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 1999;137:53-60
   PubMed Web of Science ®Google Scholar
• Mishra DK, Kumar A, Srivastava DS, Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 2004;5:362-5
   PubMedGoogle Scholar
• Vettriselvi V, Vijayalakshmi K, Paul SF, Venkatachalam P. Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev 2006;7:325-8
   PubMedGoogle Scholar
• Bu R, Gutiérrez MI, Al-Rasheed M. Variable drug metabolism genes in Arab population. Pharmacogenomics J 2004;4:260-6
   PubMed Web of Science ®Google Scholar
• Hamdy SI, Hiratsuka M, Narahara K. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 2003;55:560-9
   PubMed Web of Science ®Google Scholar
• Agalliu I, Lin DW, Salinas CA, Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate 2006;66:1535-41
   PubMed Web of Science ®Google Scholar
• Millikan R, Pittman G, Tse CK, Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000;9:567-73
   PubMed Web of Science ®Google Scholar
• Masimirembwa CM, Dandara C, Sommers DK, Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of southern Africa. Pharmacogenetics 1998;8:83-5
   PubMedGoogle Scholar
• Gaspar PA, Hutz MH, Salzano FM, Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians. Am J Phys Anthropol 2002;19:249-56
   Google Scholar
• Klautau-Guimarães MN, Hiragi CO, D'Ascenção RF, Distribution of glutathione S-transferase GSTM1 and GSTT1 null phenotypes in Brazilian Amerindians. Gen Mol Biol 2005;28:32-5
   Web of Science ®Google Scholar
• Cotton SC, Sharp LJ, Brockton N. Glutathione S transferase polymorphisms and colorectal cancer. Am J Epidemiol 1999;1-18
   Google Scholar
• Leichsenring A, Losi-Guembarovski R, Maciel ME, CYP1A1 and GSTP1 polymorphisms in an oral cancer case-control study. Braz J Med Biol Res 2006; 39:1569-74
   PubMed Web of Science ®Google Scholar
• Bosetti C, Gallus S, Franceschi S, Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers. Br J Cancer 2002;87:516-8
   PubMed Web of Science ®Google Scholar
• Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001;154:95-105
   PubMed Web of Science ®Google Scholar
• Hashibe M, Brennan P, Strange RC, Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-17
   PubMed Web of Science ®Google Scholar
• Park JL, Muscat JE, Kaur T, Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 2000;10:123-31
   PubMedGoogle Scholar
• Cho CG, Lee SK, Nam SY, Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci 2006;21:1075-9
   PubMed Web of Science ®Google Scholar
• Ruiz MT, Pavarino-Bertelli E, Maniglia JV, Epidemiologia e biomarcadores em câncer de cabeça e pescoço. Head and neck cancer epidemiology and biomarkers. Arq Ciênc Saúde 2006;13:34-8
   Google Scholar
• Minard CG, Margaret R. Spitz MR, Evaluation of Glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer 2006;106:2636-44
   PubMed Web of Science ®Google Scholar
• Jourenkova-Mironova N, Voho A, Bouchardy C, Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999;81:44-8
   PubMed Web of Science ®Google Scholar
• Jahnke V, Matthias C, Fryer A, Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg 1996;172:671-3
   PubMed Web of Science ®Google Scholar
• Katoh T, Kaneko S, Kohshi K, Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999;83:606-9
   PubMed Web of Science ®Google Scholar
• Marques CFS, Koifman S, Koifman RJ, Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 2006;42:632-7
   PubMed Web of Science ®Google Scholar
• Nazar-Stewart V, Vaughan TL, Burt RD, Glutathione S-transferase and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 1999;8:547-51
   PubMed Web of Science ®Google Scholar
• Cheng L, Sturgis E, Eicher S, Glutathione S-transferase polymorphisms and risk of squamous cell carcinoma of the head and neck. Int J Cancer 1999;84:220-4
   PubMed Web of Science ®Google Scholar
• Jain M, Kumar S, Lal P, Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev 2007;16:178-81
   PubMed Web of Science ®Google Scholar
• Sato M, Sato T, Izumo T, Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927-31
   PubMed Web of Science ®Google Scholar
• Mitrunen K, Jourenkova N, Kataja V, Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:229-36
   PubMed Web of Science ®Google Scholar
• Gudmundsdottir K, Tryggvadottir L, Eyfjord JE. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53. Gene Cancer Epidemiol Biomarkers Prev 2001;10:1169-73
   PubMed Web of Science ®Google Scholar
• Vogl FD, Taioli E, Maugard C, Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2004;13:1473-9
   PubMed Web of Science ®Google Scholar
• McCarty KM, Ryan L, Houseman EA, A case-control study of GST polymorphisms and arsenic related skin lesions. Environ Health 2007;6:5
   PubMed Web of Science ®Google Scholar
• Olsen A, Autrup H, Sorensen M, Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. Eur J Cancer Prev 2008;17:225-9
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76
   PubMed Web of Science ®Google Scholar
• Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 2009;6:281-9
   PubMed Web of Science ®Google Scholar
• White DL, Li D, Nurgalieva Z, Genetic variants of Glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 2008;167:377-89
   PubMed Web of Science ®Google Scholar
• Kiran M, Chawla YK, Kaur J. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol 2008;27:687-94
   PubMed Web of Science ®Google Scholar
• Al-Moundhri MS, Alkindy M, Al-Nabhani M, Combined polymorphism analysis of glutathione S-transferase M1/T1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab population. J Clin Gastroenterol 2009;43:152-6
   PubMed Web of Science ®Google Scholar
• Lan Q, Chow WH, Lissowska J, Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001;11:655-61
   PubMedGoogle Scholar
• Malik MA, Upadhyay R, Mittal RD, Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir valley. J Gastrointest Cancer 2009; 40:26-32
   PubMedGoogle Scholar
• Martínez C, Martín F, Fernández JM, Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006;7:711-8
   PubMed Web of Science ®Google Scholar
• Tamer L, Ateş NA, Ateş C, Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 2005;23:267-72
   PubMed Web of Science ®Google Scholar
• Boccia S, De Lauretis A, Gianfagna F, CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: a meta-analysis of the literature. Carcinogenesis 2007;28:101-6
   PubMed Web of Science ®Google Scholar
• Shibuya K, Mathers CD, Boschi-Pinto C, Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37
   PubMed Web of Science ®Google Scholar
• Cote ML, Chen W, Smith DW, Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGEGSEC review. Am J Epidemiol 2009;169:802-14
   PubMed Web of Science ®Google Scholar
• Miller DP, Asomaning K, Liu G, An association between glutathione s-transferase p1 gene polymorphism and younger age at onset of lung carcinoma. Cancer 2006;107:1570-7
   PubMed Web of Science ®Google Scholar
• Hosgood HD, Berndt SI, Lan Q. GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res 2007;636:134-43
   PubMed Web of Science ®Google Scholar
• Lee KM, Kang D, Lee SJ, Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 2006;16:1035-9
   PubMed Web of Science ®Google Scholar
• Raimondi F, Paracchini RV, Autrup H, Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006;164:1027-42
   PubMed Web of Science ®Google Scholar
• Butkiewicz D, Cole KJ, Phillips DH, GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev 1999;8:315-23
   PubMed Web of Science ®Google Scholar
• Malats N, Camus-Radon AM, Nyberg F, Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2000;9:827-33
   PubMed Web of Science ®Google Scholar
• Perera FP, Mooney LA, Stampfer M, Associations between carcinogen–DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective physicians' Health Cohort Study. Carcinog 2002;23:1641-46
   PubMed Web of Science ®Google Scholar
• Sweeney C, Nazar-Stewar V, Stapleton PL, Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev 2003;12:527-33
   PubMed Web of Science ®Google Scholar
• Murai M, Oya M. Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol 2004;14:229-33
   PubMed Web of Science ®Google Scholar
• Karami S, Boffetta P, Rothman N, Renal cell carcinoma, occupational pesticide exposure andmodification by glutathione S-transferase polymorphisms. Carcinogenesis 2008;29:1567-71
   PubMed Web of Science ®Google Scholar
• Golka K, Schmidt T, Seidel T, The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer. J Toxicol Environ Health 2008;71:881-6
   PubMed Web of Science ®Google Scholar
• García-Closas M, Malats N, Silverman D, NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the spanish Bladder Cancer study and meta-analyses. Lancet 2005;366:649-59
   PubMed Web of Science ®Google Scholar
• Engel LS, Taioli E, Pfeiffer R, Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95-109, Erratum in: Am J Epidemiol 2002;156:492
   PubMed Web of Science ®Google Scholar
• Kim WJ, Kim H, Kim CH, GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002;60:913-18
   PubMed Web of Science ®Google Scholar
• Cao W, Cai L, Rao JY, Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 2005;104:2400-8
   PubMed Web of Science ®Google Scholar
• Mittal RD, Srivastava DS, Srivastava AM, Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 2005;6:6-9
   PubMedGoogle Scholar
• Harries LW, Stubbins, MJ, Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-4
   PubMed Web of Science ®Google Scholar
• Kellen E, Hemelt M, Broberg K, Pooled analysis and meta-analysis of the Glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 2007;165:1221-30
   PubMed Web of Science ®Google Scholar
• Mo Z, Gao Y, Cao Y, An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009; 69:662-88
   PubMed Web of Science ®Google Scholar
• Ntais C, Polycarpou A, Ioannidis JPA. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14:176-81
   PubMed Web of Science ®Google Scholar
• Lima-Jr MM, Oliveira MNL, Granja F, Lack of Association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in brazilian prostate cancer patients. Folia Biol 2008;54:102-8
   PubMed Web of Science ®Google Scholar
• Medeiros R, Vasconcelos A, Costa S, Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004;58:414-20
   PubMed Web of Science ®Google Scholar
• Kesarwani P, Singh R, Mittal RD. Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk. Arch Toxicol 2009;83:351-6
   PubMed Web of Science ®Google Scholar
• Komiya Y, Tsukino H, Nakao H, Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 2005;131:238-42
   PubMed Web of Science ®Google Scholar
• Allan JM, Wild CP, Rollinson S, Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci 2001;98:11592-7
   PubMed Web of Science ®Google Scholar
• Haase D, Binder C, Bünger J, Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002;26:249-54
   PubMed Web of Science ®Google Scholar
• Barahmani N, Carpentieri S, Li XN, Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol 2009;11:292-300
   PubMed Web of Science ®Google Scholar
• Ekhart C, Rodenhuis S, Smits PH, An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev 2009;35:18-31
   PubMed Web of Science ®Google Scholar
• Montali JA, Wheatley JB, Schmidt DE Jr. Comparison of GST levels in predicting the efficacy of a novel alkylating agent. Cell Pharmacol 1996:241-7
   Google Scholar
• Tew KD, Monks A, Barone L, Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program. Mol Pharmacol 1996;50:149-59
   PubMed Web of Science ®Google Scholar
• Lo HW, Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 2007;7:367-74
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369-75
   PubMed Web of Science ®Google Scholar
• Satyam A, Hocker MD, Kane-Maguire KA, Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase, J Med Chem 1996;39:1736-1747
   Google Scholar
• McIntyre JA, Castaner J. Canfosfamide Hydrochloride. Drugs Future 2004;29:985
   Web of Science ®Google Scholar
• Meng F, Kim S, Brown GL, TLK286-induced activation of the stress response apoptotic signaling pathway. In: Proceedings of the annual meeting of the American association for cancer research, April 6–10, 2002, San Francisco, California [abstract #4772]. p. 963
   Google Scholar
• Xu H, Namgoong S-Y, Roth E, Synergistic effect of TELCYTA™ (TLK286) in combination with paclitaxel, doxorubicin, carboplatin, oxaliplatin, cisplatin, docetaxel, gemcitabine and iressa in human cancer cells. In: Proceedings of the annual meeting of the American association for cancer research, March 27–31, 2004, Orlando, Florida [abstract #2008]. p. 462
   Google Scholar
• Sequist LV, Fidias PM, Temel JS, Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. J Thorac Oncol 2009
   Google Scholar
• Vergote I, Finkler N, del Campo J, Kaye and The ASSIST-1 Study Group. Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. Eur J Cancer 2009;45:2324-32
   PubMed Web of Science ®Google Scholar